InMed Pharmaceuticals (FRA:MWG0) Accumulated Depreciation : €-1.14 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

InMed Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2023 (€-0.97 Mil) to Dec. 2023 (€-1.03 Mil) and increased from Dec. 2023 (€-1.03 Mil) to Mar. 2024 (€-1.14 Mil).

InMed Pharmaceuticals's annual accumulated depreciation increased from Jun. 2021 (€-0.19 Mil) to Jun. 2022 (€-0.49 Mil) and increased from Jun. 2022 (€-0.49 Mil) to Jun. 2023 (€-0.85 Mil).

InMed Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for InMed Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Accumulated Depreciation Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.05

-0.10

-0.19

-0.49

-0.85

InMed Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-0.77	-0.85	-0.97	-1.03	-1.14

InMed Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

InMed Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (FRA:MWG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (FRA:MWG0) Headlines

No Headlines